An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the maximum tolerated dose of E2007 in Japanese
patients with refractory partial seizures which are uncontrolled with other anti-epileptic
drugs (AEDs). Thirty patients will receive E2007 (dose escalating to the maximum of 12 mg per
day). The dose of E2007 will be adjusted during 6 weeks. Subsequently, the dose will be fixed
and maintained during 4 weeks.